| mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
0.0073 |
0.9 |
| mRNA |
BRD-A71883111 |
CTRPv2 |
pan-cancer |
AAC |
0.0072 |
0.9 |
| mRNA |
NPC-26 |
CTRPv2 |
pan-cancer |
AAC |
0.0076 |
0.9 |
| mRNA |
MK-0752 |
CTRPv2 |
pan-cancer |
AAC |
-0.0074 |
0.9 |
| mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.009 |
0.9 |
| mRNA |
BMS-270394 |
CTRPv2 |
pan-cancer |
AAC |
0.007 |
0.9 |
| mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
Compound 1541A |
CTRPv2 |
pan-cancer |
AAC |
0.0067 |
0.9 |
| mRNA |
azacitidine |
CTRPv2 |
pan-cancer |
AAC |
-0.0062 |
0.9 |